William Chou - 15 Jan 2025 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
PRESIDENT AND CEO, Director
Signature
/s/ William Chou
Issuer symbol
PASG
Transactions as of
15 Jan 2025
Net transactions value
$0
Form type
4
Filing time
29 Dec 2025, 16:14:33 UTC
Previous filing
19 Mar 2024
Next filing
18 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chou William PRESIDENT AND CEO, Director ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA /s/ William Chou 29 Dec 2025 0001949693

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Restricted Stock Unit Award $0 +20,000 $0.000000 20,000 15 Jan 2025 Common Stock 20,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 50% of the total RSUs will vest on January 8, 2026 and the remaining 50% of the RSUs will vest on January 8, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Remarks:

Reflects reverse stock split effected by the issuer on July 14, 2025.